Niki BioSolutions/$NIKI
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Niki BioSolutions
Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Its activities include the development and application of proprietary technologies to support precision medicine across therapeutic areas including brain health and oncology. The company also collaborates with academic centers, disease foundations, and biopharmaceutical companies.
- Ticker
- $NIKI
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Princeton, United States
- Website
- www.aptorumgroup.com
NIKI Metrics
BasicAdvanced
$4.6M
-
-$2.86
-0.83
-
Price and volume
Market cap
$4.6M
Beta
-0.83
52-week high
$10.39
52-week low
$1.42
Average daily volume
19K
Financial strength
Current ratio
0.451
Quick ratio
0.407
Total debt to equity
0.282
Interest coverage (TTM)
-26.71%
Profitability
Management effectiveness
Return on assets (TTM)
-10.04%
Return on equity (TTM)
-17.05%
Valuation
Price to book
0.06
Price to tangible book (TTM)
0.06
Price to free cash flow (TTM)
-0.479
Free cash flow yield (TTM)
-208.56%
Free cash flow per share (TTM)
-3.274
Growth
Earnings per share change (TTM)
-12.15%
3-year earnings per share growth (CAGR)
-57.08%
NIKI Financial Performance
Revenues and expenses
NIKI Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.